Pustular skin lesions in patients treated with infliximab: report of two cases
- First Online:
- Cite this article as:
- Starmans-Kool, M.J.F., Peeters, H.R.M. & Houben, H.H.M.L. Rheumatol Int (2005) 25: 550. doi:10.1007/s00296-004-0567-5
Two cases are presented in which repeated use of the TNF-α blocker infliximab may have led to development of pustular skin lesions. These findings might result in an improved understanding regarding the safety of infliximab with long-term usage.